story of the week
Eliminating Breast Surgery for Invasive Breast Cancer in Exceptional Responders to Neoadjuvant Systemic Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
Lancet Oncol 2022 Oct 25;[EPub Ahead of Print], HM Kuerer, BD Smith, S Krishnamurthy, WT Yang, V Valero, Y Shen, H Lin, A Lucci, JC Boughey, RL White, EJ Diego, GM RauchFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.